Please login to the form below
Evotec
This page shows the latest Evotec news and features for those working in and with pharma, biotech and healthcare.
LSTM and LifeArc announce partnership and research fund to tackle infectious diseases
As well as LifeArc, core partners of iiCON, a £250m programme, include Unilever, Evotec, Liverpool University Hospitals Foundation Trust, the University of Liverpool and Infex Therapeutics.
Latest news
-
Sandoz launches high-concentration biosimilar of AbbVie’s Humira in the US
Sandoz announced a partnership with Just-Evotec Biologics in May aimed at developing and manufacturing multiple biosimilar candidates with an option for expansion. ... The multi-year collaboration grants Sandoz access to Just-Evotec Biologics’
-
Sandoz and Just-Evotec Biologics announce multi-year biosimilar partnership
Sandoz and Just-Evotec Biologics have announced a partnership aimed at developing and manufacturing multiple biosimilar candidates with an option for expansion. ... Just-Evotec Biologics has developed what Sandoz describes as "an optimised proprietary
-
Evotech, Boehringer Ingelheim and bioMérieux launch joint venture to combat antimicrobial resistance
The collaboration will unite Evotec’s expertise on infectious disease research, bioMérieux’s expertise in infectious disease diagnostics and Boehringer Ingelheim’s broad drug discovery and significant clinical development capabilities.
-
Almirall and Evotec team up in multi-target dermatology alliance
Evotec will oversee drug discovery and pre-clinical development, while Almirall will lead the clinical development and marketing. ... We are looking forward to leveraging the complementary expertise of Evotec and Almirall in order to develop promising
-
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
It remains firmly committed to women’s health however, and just last week added to its pipeline in this area by signing a five-year research alliance with Evotec focusing on ... The Evotec and Daré deals sandwiched two other agreements signed in the
More from news
Approximately 18 fully matching, plus 27 partially matching documents found.
Latest Intelligence
-
Alzheimer’s disease: the search for a cure
The companies, Abbvie, Astex Pharmaceuticals, Eisai, Johnson &Johnson, Lilly, MSD and Takeda, Evotec and Charles River, participate in research projects alongside academic scientists.
-
A snapshot of… Exscientia
We’ve also signed numerous major pharma collaborations with companies including Roche, Celgene, Sanofi, GSK and Evotec, estimated to be worth over $1bn in milestones and royalties.
-
Brain power: fresh approaches to Alzheimer’s drug discovery
Last month, Johnson &Johnson Innovation, Takeda and Evotec became the latest pharma research groups to join the initiative, alongside existing strategic partners AbbVie, Astex Pharmaceuticals, Eisai, Lilly and MSD. ... We’re excited to welcome Johnson
-
Pharma deals continue to slide
For example, Evotec, the German small molecule development company, is acquiring for $300m the US preclinical development company, Aptuit. ... 400. Aptuit (US). Evotec (DE). Company acquisition. Drug discovery and development to IND submission including
-
Deal Watch December 2016
320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... upfront. And although the upfronts are a modest percentage of the headline figure, ranging from < 1% (BioInvent) to 15%
More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Apitope strengthens its board with new director
He has also served on several boards including Ablynx, Evotec and Acambis.
-
Evotec CEO Werner Lanthaler temporarily stands down
Cites health reasons. Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Breaking the silence: It’s time to talk about the menopause
According to Werner Lanthaler, CEO of Evotec AG (a long-time partner of Bayer AG, well-known for their role in advocating for women’s health) in an interview with In
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
